Vimian Group AB
STO:VIMIAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vimian Group AB
STO:VIMIAN
|
SE |
Intrinsic Value
The intrinsic value of Vimian Group AB (VIMIAN) under the Base Case is 35.74 SEK per share. Compared with the current market price of 40.9 SEK, the stock appears Overvalued by 13% .
The intrinsic value is calculated using the DCF method. The model assumes operating margin rises from 16% last year to 21% by 2031, higher than in any of the last six years. If operating margin stayed at its five-year average of 15%, the estimate would be about kr23.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Vimian Group AB Does
Vimian Group AB is an animal health company that sells products and services used to care for pets and other animals. Its business is built around veterinary medicine, animal diagnostics, and specialized medical devices and consumables, with a strong focus on dogs and cats. It serves veterinarians, animal hospitals, distributors, and other animal health professionals who need tools to diagnose, treat, and monitor animals.
- Headquarters
- Sweden SE
- Employees
- 1 300
- IPO date
- Jun 18, 2021
Earnings Waterfall
Vimian Group AB
The intrinsic value for Vimian Group AB (VIMIAN) under the Base Case is 35.74 SEK.
Compared with the current market price of 40.9 SEK, the stock appears Overvalued by 13% .